CorrlensCorrlens
Correlate

Correlation Analysis

VISA Inc. vs Vertex Pharmaceuticals Inc

V vs VRTX

+0.776

Strong positive

When one moves up, the other tends to follow.

V

VISA Inc.

V

Visa is the largest payment processor in the world. In fiscal 2025, it processed almost $17 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.

Market cap 583.4B

VRTX logo

Vertex Pharmaceuticals Inc

VRTX

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Market cap 110.5B · 6,400 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockFinancialsHealthcare

Time Series

Relative Performance

Green: VGray: VRTX36 of 1,254 points (sampled)

Who Moves First

VRTX leads V by 6 days

VRTX tends to move before V.

After testing 13 timing shifts, the strongest relationship was +0.778 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.546

11 periods · Return correlation when both series rose

Both Falling

+0.206

7 periods · Return correlation when both series fell

Diverging

-0.653

17 periods · Return correlation when series moved apart

R-Squared

60.2%

Share of variance in one series explained by the other.

Trend Agreement

59.2%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.753, 0.797]

Scatter

XY Regression

192.8200250300350372.1161.2200250300350400450500512.3VISA Inc.Vertex Pharmaceuticals IncData pointsFit (r = 0.776)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

V

VISA Inc.

V

Market cap 583.4B

Stock · 1,254 raw → 1,254 prepared

Series B

VRTX logo

Vertex Pharmaceuticals Inc

VRTX

Market cap 110.5B · 6,400 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

27

Estimated crossover points between normalized spreads.

Slope

1.4807

Linear regression slope.

Intercept

-34.5226

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 6 hours ago · ID: stock-v-vs-stock-vrtx-daily